The lancet oncology
-
The lancet oncology · Jan 2016
Comparative StudyCancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study.
Cancer drugs challenge health-care systems because of their high prices. No cross-country price comparison of cancer drugs for a large number of countries has been published. We aimed to survey the prices of cancer drugs in high-income countries (Europe, Australia, and New Zealand). ⋯ None.